SV Health Investors’s Bicycle Therapeutics BCYC Stock Holding History

SV Health Investors’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$21.1M	Hold	907,032	–	–	65.36%	1
2022 Q2	$15.2M	Sell	907,032 -10,186	-1%	-$215K	34.74%	2
2022 Q1	$40.2M	Sell	917,218 -936	-0.1%	-$43.7K	48.61%	1
2021 Q4	$55.9M	Sell	918,154 -518,302	-36%	-$28.6M	36.13%	1
2021 Q3	$59.7M	Sell	1,436,456 -478,818	-25%	-$16.7M	29.23%	1
2021 Q2	$58.1M	Hold	1,915,274	–	–	25.33%	2
2021 Q1	$57.2M	Hold	1,915,274	–	–	21.43%	2
2020 Q4	$34.4M	Hold	1,915,274	–	–	16.56%	3
2020 Q3	$36.5M	Hold	1,915,274	–	–	18.49%	2
2020 Q2	$30.1M	Hold	1,915,274	–	–	20.91%	1
2020 Q1	$26.1M	Hold	1,915,274	–	–	21.93%	1
2019 Q4	$18.1M	Hold	1,915,274	–	–	10.94%	6
2019 Q3	$21.8M	Hold	1,915,274	–	–	15.32%	2
2019 Q2	$19.3M	Buy	+1,915,274	New	+$23.1M	12.93%	5

Other funds holding BCYC

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return